Chemo-Free Induction for Mantle Cell Impresses (CME/CE)

(MedPage Today) -- Response rate of 100% with ibrutinib-rituximab combination

Source: MedPage Today Meeting Coverage - December 6, 2016 Category: Journals (General) Source Type: news